Erschienen in:
01.04.2016 | Capsule Commentary
Capsule Commentary on Tosteson et al., Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium
verfasst von:
Victor O. Kolade, MD, Marcelle G. Meseeha, MD
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 4/2016
Einloggen, um Zugang zu erhalten
Excerpt
Reporting of cancer screening rates in the United States has been fraught with much variability, but maintains great importance with respect to cancer morbidity and mortality as well as related health disparities.
1 The situation is complicated by changes in national guidelines.
2 …